Q » What are the risks associated with drug delivery systems be optimized during drug trials?
31 Oct, 2025
A » Optimizing drug delivery systems during trials poses risks such as unexpected side effects, altered drug efficacy, and increased complexity in assessing trial outcomes. These changes can complicate regulatory compliance and patient safety monitoring. Careful planning and robust preclinical testing are crucial to mitigate these risks, ensuring that modifications enhance therapeutic effectiveness without compromising safety or trial integrity.
31 Oct, 2025
Still curious? Ask our experts.
Chat with our AI personalities
I'm here to listen you
Taiga
Keep pushing forward.
Always by your side.
Play the long game.
Focus on what matters.
Keep asking, keep learning.